Abstract
The efficacy of transdermal therapeutic system scopolamine (TTS scopolamine) has been evaluated in six patients with confirmed Meniere's disease, who can recognize themselves relatively definite prodromal symptoms several hours before occurrence of intractable vertigious spell and has relatively severe autonomic nervous disorder symptoms. At onset of prodromal symptoms, one sheet of TTS scopolamine was applied to a dried postauricular skin and it was left unremoved for three days. Clinical observations suggested that TTS scopolamine could control feeling of vertigo in four of the six patients and autonomic nervous symptom in five of the six patients. The application of TTS generally alleviated the onset of scopolamine's side effects. However, adverse effect of blurred vision and dryness of the mouth were noticed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
